MedTrace Logo

Oocyte Recipient's Decision in the Number of Embryos to be Transferred

NCT03185715 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-06-14

No results posted yet for this study

Summary

Multiple pregnancies are considered an ART complication. The only effective way to reduce its incidence is to transfer a single embryo. Nonetheless, there is some reluctance among the patients to accept this strategy. In IVF/ICSI programs, it has been demonstrated that, after receiving the information about the similar cumulative live birth rate after single embryo transfer (SET) and double embryo transfer (DET) and the obstetric and perinatal risks of multiple pregnancy, a significant number of patients opt for SET. Up to date, no comparable studies have been published in oocyte recipients. The aim of this study is to evaluate if the information given to the patients influence their preference on the number of embryos to be transferred. It also seeks to identify factors which determine the initial preference and factors which can explain a hypothetic change in this preference.

Conditions

  • Decision Making
  • Infertility, Female
  • Counseling

Interventions

BEHAVIORAL

Oral and written counselling

Recipients were informed about success rates of SET and DET and also about the possible risks of DET. All the information was given orally and written.

Sponsors & Collaborators

  • Fundacion Dexeus

    lead OTHER

Principal Investigators

  • Elisabet Clua, PhD · Fundacion Dexeus

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-05-31
Completion
2017-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03185715 on ClinicalTrials.gov